Literature DB >> 19204350

Johne's disease in a free-ranging white-tailed deer from Virginia and subsequent surveillance for Mycobacterium avium subspecies paratuberculosis.

Jonathan M Sleeman1, Elizabeth J B Manning, John H Rohm, Jerry P Sims, Susan Sanchez, Richard W Gerhold, M Kevin Keel.   

Abstract

Johne's disease (paratuberculosis) was diagnosed in a 2-yr-old, male, free-ranging white-tailed deer (Odocoileus virginianus) from Fauquier County, Virginia, USA, based on histopathology and culture for Mycobacterium avium subspecies paratuberculosis. Clinical and pathologic findings included emaciation; loss of body fat; chronic diarrhea; severe, chronic, diffuse granulomatous colitis with intrahistiocytic acid-fast bacilli; moderate, chronic granulomatous lymphadenitis with intrahistiocytic acid-fast bacilli; as well as moderate chronic, multifocal, lymphoplasmacytic hepatitis. These findings are consistent with previous reports of Johne's disease in cervids. Subsequent targeted surveillance of 10 emaciated deer with diarrhea, as well as sampling of 72 asymptomatic deer for M. avium subsp. paratuberculosis using culture of multiple tissue types, as well as serology using an enzyme-linked immunosorbent assay (ELISA) optimized for cervid antibody detection, did not reveal any additional cases of infection in this geographic region. To date, this appears to be an isolated case of Johne's disease in a free-ranging white-tailed deer, and infection with the causative agent for Johne's disease appears to be an infrequent occurrence in deer from this region. The origin of infection was most likely domestic ruminants. This is the first report of clinical Johne's disease in a free-ranging white-tailed deer outside of the Florida Keys, USA. Stressors, such as high deer population density and low selenium levels, may have contributed to the development of clinical disease in this case and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204350     DOI: 10.7589/0090-3558-45.1.201

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  6 in total

1.  Characteristics of subclinical Mycobacterium avium ssp. paratuberculosis infection in a captive white-tailed deer herd.

Authors:  Mitchell V Palmer; Carly Kanipe; Rebecca Cox; Suelee Robbe-Austerman; Tyler C Thacker
Journal:  J Vet Diagn Invest       Date:  2019-09-11       Impact factor: 1.279

2.  Development of a novel oral vaccine against Mycobacterium avium paratuberculosis and Johne disease: a patho-biotechnological approach.

Authors:  C Johnston; A Coffey; Jim O' Mahony; R D Sleator
Journal:  Bioeng Bugs       Date:  2009-10-23

3.  Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine model.

Authors:  Syed M Faisal; Jenn-Wei Chen; Falong Yan; Tsai-Tzu Chen; Nicodemus M Useh; Weiwei Yan; Shanguang Guo; Shih-Jon Wang; Amy L Glaser; Sean P McDonough; Bhupinder Singh; William C Davis; Bruce L Akey; Yung-Fu Chang
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

4.  The modification and evaluation of an ELISA test for the surveillance of Mycobacterium avium subsp. paratuberculosis infection in wild ruminants.

Authors:  Mathieu Pruvot; Taya L Forde; Jillian Steele; Susan J Kutz; Jeroen De Buck; Frank van der Meer; Karin Orsel
Journal:  BMC Vet Res       Date:  2013-01-09       Impact factor: 2.741

5.  Beyond the disease: Is Toxoplasma gondii infection causing population declines in the eastern quoll (Dasyurus viverrinus)?

Authors:  Bronwyn A Fancourt; Stewart C Nicol; Clare E Hawkins; Menna E Jones; Chris N Johnson
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-05-29       Impact factor: 2.674

6.  Ecological drivers of Mycobacterium avium subsp. paratuberculosis detection in mongoose (Herpestes ichneumon) using IS900 as proxy.

Authors:  Mónica V Cunha; Luís Miguel Rosalino; Célia Leão; Victor Bandeira; Carlos Fonseca; Ana Botelho; Ana C Reis
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.